Tradewind BioScience
Novel approaches for the treatment of the most aggressive cancers
Tradewind BioScience
Novel approaches for the treatment of the most aggressive cancers
Novel approaches for the treatment of the most aggressive cancers
Novel approaches for the treatment of the most aggressive cancers
Our mission is to develop drugs that attack the most aggressive human cancers. We aim for transformative medicines that will make a large difference for patients.
Our drug development is science-driven. Tradewind was formed to translate science developed by its founders into novel drugs, so we bring expertise, assays and proprietary knowledge to the table.
We couple our drug development with a focus on biomarker identification. We aim to pick out the patients that will benefit most from the medicines we are developing.
Copyright © 2021 Tradewind BioScience - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.